Luye Pharma Group Ltd.
Luye Pharma Group Ltd. (LYPHF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · LYPHF · as of Jun 9, 2026
Key Statistics
Explore Luye Pharma Group Ltd. Data
lyphf stock data · financialsFinancial Snapshot
Full FinancialsCompetitors & Peers
lyphf competitorsLYPHF
AIHLF
BITGF
BTTAY
CMPUY
CMPVFStock Performance
Full HistoryAbout Luye Pharma Group Ltd.
Luye Pharma Group Ltd. serving as an investment holding company, engages in the global research, development, production, commercialization, and distribution of a diverse portfolio of pharmaceutical …
what is luye pharma group ltd. · lyphf stock overview · luye pharma group ltd. company profile · who is luye pharma group ltd. ceo · lyphf OTC · luye pharma group ltd. headquarters · luye pharma group ltd. business segments
About Stock Overview & Key Data
Luye Pharma Group Ltd. (LYPHF) is a Healthcare company in the Drug Manufacturers - General industry, listed on OTC since Feb 18, 2021. As of the latest trading session, LYPHF stock price is $0.40, with a market capitalization of $1.6B. The stock has returned +47.39% over the past 12 months and +1.21% year-to-date.
In fiscal year 2025, Luye Pharma Group Ltd. reported revenue of $6.1B. For detailed financial data including revenue history, earnings, and balance sheet — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Luye Pharma Group Ltd. (LYPHF) stock price is $0.40. The stock is traded on OTC under the ticker symbol LYPHF. The 52-week range is $0.27 – $0.40.